Mannitol & MANNITOL 2080 Excipient Use in Iv Infusion Dosage Forms

Mannitol

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

39 Listed Products, 1 Ingredion Pharma Solutions, 1 Pfanstiehl, 11 Roquette, 12 SPI Pharma, 1 Shijiazhuang Huaxu Pharmaceutical, 2 Microlex e.U, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Gangwal Healthcare, 1 DKSH, 2 Gangwal Chemicals, 1 BASF, 2 Kerry, 1 Rochem International Inc, 1 Sigachi Industries

REGULATORY FILINGS

13 Suppliers, 12 USDMF, 3 CEP/COS, 3 NDC API

SOLUTIONS BY APPLICATIONS

25 Fillers, Diluents & Binders, 10 Direct Compression, 10 Chewable & Orodispersible Aids, 9 Taste Masking, 4 Co-Processed Excipients, 4 Parenteral, 3 Granulation, 3 Disintegrants & Superdisintegrants, 1 API Stability Enhancers, 1 Thickeners and Stabilizers

ANALYTICAL SOLUTION(s)

1 Other Ref. Standards

1 Other Ref. Standards

FINISHED FORMULATIONS

414 ORAL, 229 TABLET, 114 INJECTABLE, 79 INJECTION, 62 TABLET, ORALLY DISINTEGRATING, 50 INTRAVENOUS, 29 OPHTHALMIC, 27 CAPSULE, 24 SOLUTION/DROPS, 24 TABLET, CHEWABLE, 22 POWDER, 22 TABLET, DELAYED RELEASE, 20 TABLET, EXTENDED RELEASE, 19 SUBLINGUAL, 14 FOR SUSPENSION, 11 CAPSULE, DELAYED REL PELLETS, 8 BUCCAL, 8 GUM, CHEWING, 8 SOLUTION, 8 SUBCUTANEOUS, 6 FOR SOLUTION, 6 GRANULE, 5 INTRAMUSCULAR, 5 TABLET, FOR SUSPENSION, 5 TROCHE/LOZENGE, 4 CAPSULE, EXTENDED RELEASE, 4 INTRAVENOUS, SUBCUTANEOUS, 3 VIAL, 2 BUCCAL, SUBLINGUAL, 2 ORAL-21, 2 ORAL-28, 2 SUSPENSION/DROPS, 2 TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE, 1 CAPSULE, DELAYED RELEASE, 1 FOR SUSPENSION, DELAYED RELEASE, 1 FOR SUSPENSION, EXTENDED RELEASE, 1 GEL, 1 INJECTABLE, LIPOSOMAL, 1 INJECTABLE, TABLET, 1 INTRAMUSCULAR, ORAL, 1 INTRAVITREAL, 1 IV (INFUSION), 1 NASAL, 1 SINGLE-USE, 1 SOLUTION, GEL FORMING/DROPS, 1 SPRAY, METERED, 1 SUSPENSION, 1 TABLET, EXTENDED RELEASE, CHEWABLE, 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE